Listed

Mimedx Group, Inc.

MDXGNasdaqCIK 1376339HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$64.4mRevenue, Q2 FY2026, three months to 2026-06-30$64.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Jul 29, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$64.4mRevenue, Q2 FY2026, three months to 2026-06-30$64.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Report this figure−34.7% on a year earlier
  • Gross margin69.0%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $44.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Revenue: $64.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Report this figure−12.1 pts on a year earlier
  • Operating margin−28.7%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$18.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Revenue: $64.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Report this figure−41.2 pts on a year earlier
  • Net margin−23.1%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$14.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Revenue: $64.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Report this figure−32.8 pts on a year earlier
  • Diluted EPS−$0.10Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Report this figureSign changed from a year earlier
  • Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare

Last eight quarters

Full statements
Revenue$64.4mGross margin 69.0%
Diluted EPS−$0.10, Q2 FY2026
Mimedx Group, Inc., key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m84.1Revenue, Q3 FY2024, three months to 2024-09-30$84.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001376339-25-000103.Report this figure92.9Revenue, Q4 FY2024, three months to 2024-12-31$92.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001376339-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure88.2Revenue, Q1 FY2025, three months to 2025-03-31$88.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001376339-26-000031.Report this figure98.6Revenue, Q2 FY2025, three months to 2025-06-30$98.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Report this figure114Revenue, Q3 FY2025, three months to 2025-09-30$113.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001376339-25-000103.Report this figure118Revenue, Q4 FY2025, three months to 2025-12-31$118.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001376339-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure59.0Revenue, Q1 FY2026, three months to 2026-03-31$59.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001376339-26-000031.Report this figure64.4Revenue, Q2 FY2026, three months to 2026-06-30$64.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Report this figure
Gross margin%81.8%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $68.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-29, accession 0001376339-25-000103.Revenue: $84.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001376339-25-000103.Report this figure81.8%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $76.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0001376339-26-000011. Derived: 12-month figure less the 9-month figure.Revenue: $92.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001376339-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure81.2%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $71.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-29, accession 0001376339-26-000031.Revenue: $88.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001376339-26-000031.Report this figure81.1%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $79.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Revenue: $98.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Report this figure83.5%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $95.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-29, accession 0001376339-25-000103.Revenue: $113.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001376339-25-000103.Report this figure83.9%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $99.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0001376339-26-000011. Derived: 12-month figure less the 9-month figure.Revenue: $118.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001376339-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure70.6%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $41.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-29, accession 0001376339-26-000031.Revenue: $59.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001376339-26-000031.Report this figure69.0%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $44.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Revenue: $64.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Report this figure
Operating margin%13.3%Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: $11.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-29, accession 0001376339-25-000103.Revenue: $84.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001376339-25-000103.Report this figure11.9%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $11.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001376339-26-000011. Derived: 12-month figure less the 9-month figure.Revenue: $92.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001376339-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure9.4%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $8.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-29, accession 0001376339-26-000031.Revenue: $88.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001376339-26-000031.Report this figure12.5%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $12.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Revenue: $98.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Report this figure19.5%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $22.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-29, accession 0001376339-25-000103.Revenue: $113.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001376339-25-000103.Report this figure17.8%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $21.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001376339-26-000011. Derived: 12-month figure less the 9-month figure.Revenue: $118.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001376339-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(27.2%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$16.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-29, accession 0001376339-26-000031.Revenue: $59.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001376339-26-000031.Report this figure(28.7%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$18.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Revenue: $64.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Report this figure
Net margin%9.6%Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: $8.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-29, accession 0001376339-25-000103.Revenue: $84.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001376339-25-000103.Report this figure8.0%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $7.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001376339-26-000011. Derived: 12-month figure less the 9-month figure.Revenue: $92.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001376339-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure8.0%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $7.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-29, accession 0001376339-26-000031.Revenue: $88.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001376339-26-000031.Report this figure9.8%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $9.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Revenue: $98.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Report this figure14.7%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $16.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-29, accession 0001376339-25-000103.Revenue: $113.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001376339-25-000103.Report this figure12.9%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $15.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001376339-26-000011. Derived: 12-month figure less the 9-month figure.Revenue: $118.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001376339-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(18.4%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$10.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-29, accession 0001376339-26-000031.Revenue: $59.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001376339-26-000031.Report this figure(23.1%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$14.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Revenue: $64.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Report this figure
Diluted EPS$ per share0.05Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-29, accession 0001376339-25-000103.Report this figurenot reported (Diluted EPS not reported)0.05Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0001376339-26-000031.Report this figure0.06Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Report this figure0.11Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-29, accession 0001376339-25-000103.Report this figurenot reported (Diluted EPS not reported)(0.07)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0001376339-26-000031.Report this figure(0.10)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0001376339-26-000071.Report this figure
Free cash flow$mnot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$418.6mGross margin 82.6%
Diluted EPS$0.32, FY2025
Free cash flow$24.8m, FY2023
Mimedx Group, Inc., key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m242Revenue, FY2021, twelve months to 2021-12-31$242.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-28, accession 0001376339-24-000009.Report this figure268Revenue, FY2022, twelve months to 2022-12-31$267.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-26, accession 0001376339-25-000009.Report this figure321Revenue, FY2023, twelve months to 2023-12-31$321.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001376339-26-000011.Report this figure349Revenue, FY2024, twelve months to 2024-12-31$348.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001376339-26-000011.Report this figure419Revenue, FY2025, twelve months to 2025-12-31$418.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001376339-26-000011.Report this figure
Gross margin%83.6%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $202.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-02-28, accession 0001376339-24-000009.Revenue: $242.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-28, accession 0001376339-24-000009.Report this figure82.0%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $219.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-26, accession 0001376339-25-000009.Revenue: $267.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-26, accession 0001376339-25-000009.Report this figure83.0%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $266.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0001376339-26-000011.Revenue: $321.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001376339-26-000011.Report this figure82.8%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $288.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0001376339-26-000011.Revenue: $348.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001376339-26-000011.Report this figure82.6%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $345.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0001376339-26-000011.Revenue: $418.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001376339-26-000011.Report this figure
Operating margin%(2.9%)Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: −$7.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-28, accession 0001376339-24-000009.Revenue: $242.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-28, accession 0001376339-24-000009.Report this figure(5.5%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$14.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-26, accession 0001376339-25-000009.Revenue: $267.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-26, accession 0001376339-25-000009.Report this figure11.5%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $37.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001376339-26-000011.Revenue: $321.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001376339-26-000011.Report this figure16.9%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $58.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001376339-26-000011.Revenue: $348.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001376339-26-000011.Report this figure15.3%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $63.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001376339-26-000011.Revenue: $418.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001376339-26-000011.Report this figure
Net margin%(4.2%)Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: −$10.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-28, accession 0001376339-24-000009.Revenue: $242.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-28, accession 0001376339-24-000009.Report this figure(11.3%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$30.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-26, accession 0001376339-25-000009.Revenue: $267.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-26, accession 0001376339-25-000009.Report this figure18.1%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $58.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001376339-26-000011.Revenue: $321.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001376339-26-000011.Report this figure12.2%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $42.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001376339-26-000011.Revenue: $348.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001376339-26-000011.Report this figure11.6%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $48.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001376339-26-000011.Revenue: $418.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001376339-26-000011.Report this figure
Diluted EPS$ per share(0.15)Diluted EPS, FY2021, twelve months to 2021-12-31−$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-28, accession 0001376339-24-000009.Report this figure(0.33)Diluted EPS, FY2022, twelve months to 2022-12-31−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-26, accession 0001376339-25-000009.Report this figure0.37Diluted EPS, FY2023, twelve months to 2023-12-31$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-25, accession 0001376339-26-000011.Report this figure0.28Diluted EPS, FY2024, twelve months to 2024-12-31$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-25, accession 0001376339-26-000011.Report this figure0.32Diluted EPS, FY2025, twelve months to 2025-12-31$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-25, accession 0001376339-26-000011.Report this figure
Free cash flow$m(5.2)Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: −$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-28, accession 0001376339-24-000009.Capital expenditure: $3.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-28, accession 0001376339-24-000009.Report this figure(19.4)Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: −$17.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-26, accession 0001376339-25-000009.Capital expenditure: $1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-28, accession 0001376339-24-000009.Report this figure24.8Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $26.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001376339-26-000011.Capital expenditure: $2.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-28, accession 0001376339-24-000009.Report this figurenot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Mimedx Group, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
Essex Woodlands Management, Inc.2026-06-30$108.6m28,195,249Unchanged
BlackRock, Inc.2026-06-30$46.8m12,154,466Added+243,166
Trigran Investments, Inc.2026-06-30$27.6m7,173,770Reduced−1,339
STATE STREET CORP2026-06-30$21.5m5,578,920Added+522,119
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$20.0m5,187,053Added+21,047
Nantahala Capital Management, LLC2026-06-30$18.4m4,767,552Added+1,370,253
Nantahala Capital Management, LLC2026-06-30$18.4m4,767,552Added+1,370,253
PARADIGM CAPITAL MANAGEMENT INC/NY2026-06-30$15.7m4,073,100Added+662,800
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$12.1m3,143,488Added+262,329
GOLDMAN SACHS GROUP INC2026-06-30$10.3m2,665,562Added+1,480,001

Recent filings

All 1,205 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Mimedx Group, Inc., recent filings
FiledFormWhat it isAccession number
2026-10-1613:01 ET8-K8.01 Other events0001213900-26-110041
2026-08-1120:44 ET8-K/A1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001376339-26-000082
2026-07-2920:08 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001376339-26-000074
2026-07-2920:06 ET10-QQuarterly reportPeriod 2026-06-300001376339-26-000071
2026-07-2920:03 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001376339-26-000070
2026-06-1620:12 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results0001376339-26-000052
2026-04-2920:02 ETDEF 14AProxy statementPeriod 2025-12-310001376339-26-000033
2026-04-2920:01 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001376339-26-000032
2026-04-2920:00 ET10-QQuarterly reportPeriod 2026-03-310001376339-26-000031
2026-04-1612:04 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001376339-26-000021

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 25, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1376339
Tickers
MDXG
Exchange
Nasdaq
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
not reported
Filer category
Large accelerated filer
Former names
Alynx, Co. (to 2008-04-02)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.